The US Government keeps an online database, at clinicaltrials.gov, of clinical research studies for Mesothelioma cancer, but doesn't review or approve the safety and science of these trials. The website is maintained by the National Library of Medicine (NLM). The links below go to the clinical trial information on clinicaltrials.gov. Talk with your health care professional about possible risks and benefits before joining any studies.
Tue, 22 Apr 2025 00:00:00 EDT
Conditions: Mesothelioma; Non Small Cell Lung Cancer; Malignant Peripheral Nerve Sheath Tumors; Solid Tumor; Pancreatic Adenocarcinoma; Advanced Solid Tumor
Interventions: Drug: MRTX1719
Sponsors: Bristol-Myers Squibb
Recruiting
Sun, 13 Apr 2025 00:00:00 EDT
Conditions: Risk of Breast Cancer; Risk of Gynaecological Cancer; Risk of Colorectal Cancer; Risk of Upper Gastrointestinal Cancers; Risk of Hepatic Cancers; Risk of Lung Cancer; Risk of Skin Cancers Except Basal-cell Carcinomas; Risk of Head and Neck Cancers; Risk of Mesothelioma; Risk of Kidney Cancer; Risk of Prostate Cancer; Risk of Urothelial Cancers; Risk of Endocrine Cancers; Risk of Hematologic Malignancies; Risk of Several Cancer Types; Risk of Second Malignancy in Individuals Treated for a Childhood Cancer; Risk of Neoplasia
Interventions: Diagnostic Test: biological samples
Sponsors: Gustave Roussy, Cancer Campus, Grand Paris
Not yet recruiting
Fri, 25 Apr 2025 00:00:00 EDT
Conditions: Mesothelioma; Malignant Mesothelioma (MM); Early-stage Mesothelioma; Subclinical Mesothelioma; BRCA1-Associated Protein-1 (BAP1) Mutations; Early-stage BAP1-associated Malignancies
Interventions: Drug: alrizomadlin
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
Tue, 15 Apr 2025 00:00:00 EDT
Conditions: Thoracic Solid Malignant Tumor
Interventions: Radiation: BNCT; Diagnostic Test: [18F]FBPA
Sponsors: Stella Pharma Corporation; Cancer Intelligence Care Systems, Inc.; Sumitomo Heavy Industries, Ltd.
Enrolling by invitation
Sun, 13 Apr 2025 00:00:00 EDT
Conditions: Mesothelioma; Mesotheliomas Pleural; Mesothelioma; Pleura
Interventions: Drug: Sacituzumab govitecan-hziy
Sponsors: Memorial Sloan Kettering Cancer Center; Gilead Sciences
Recruiting
Sun, 20 Apr 2025 00:00:00 EDT
Conditions: Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Pancreatic Adenocarcinoma; Colorectal Neoplasms; Mesothelioma; Other Solid Tumors; Endometrial
Interventions: Drug: PF-08052666
Sponsors: Seagen, a wholly owned subsidiary of Pfizer
Recruiting
Thu, 24 Apr 2025 00:00:00 EDT
Conditions: Unresectable Pleural Mesothelioma
Interventions: Drug: Volrustomig; Drug: Pemetrexed; Drug: Carboplatin; Drug: Cisplatin; Drug: Nivolumab; Drug: Ipilimumab
Sponsors: AstraZeneca
Recruiting
Sun, 20 Apr 2025 00:00:00 EDT
Conditions: Advanced Renal Cell Carcinoma; Advanced Mesothelioma; Advanced Osteosarcoma
Interventions: Drug: CAR.70/IL15-transduced CB-derived NK cells; Drug: Fludarabine phosphate; Drug: Cyclophosphamide
Sponsors: M.D. Anderson Cancer Center
Recruiting
Sun, 20 Apr 2025 00:00:00 EDT
Conditions: High Grade Epithelial Ovarian Cancer; High Grade Serous Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer; Endometrial Cancer; Non-small Cell Lung Cancer; Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC); Mesothelioma; Breast Adenocarcinoma; Triple Negative Breast Cancer; Hormone Receptor-positive/Her2 Negative Breast Cancer; Platinum-resistant Ovarian Cancer (PROC); Platinum Sensitive Ovarian Cancer (PSOC); Primary Refractory Ovarian Cancer; Uterine Cancer
Interventions: Drug: Rina-S; Drug: Carboplatin; Drug: Bevacizumab; Drug: Pembrolizumab
Sponsors: Genmab
Recruiting
Sun, 13 Apr 2025 00:00:00 EDT
Conditions: Cutaneous Melanoma; Non-small Cell Lung Cancer; Colorectal Neoplasms; Pancreatic Neoplasms; Mesothelioma
Interventions: Drug: PF-08046049
Sponsors: Seagen, a wholly owned subsidiary of Pfizer
Active, not recruiting
Menu